{"transactions":[{"id":916390,"issuer":{"id":7876,"kind":"organization","name":"Quoin Pharmaceuticals Ltd."},"owners":[{"id":67443,"kind":"person","name":"SEMBER MICHAEL T","position":1,"cik":"0001107486","reported_name":"SEMBER MICHAEL T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2026-02-06T17:14:15.000Z","date":"2026-02-04","kind":"grant","planned":false,"acquired":true,"shares":8141,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares (\"ADSs\"). Each ADS represents thirty-five ordinary shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F1","text":"The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares (\"ADSs\"). Each ADS represents thirty-five ordinary shares of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in four annual installments with 20% vesting on each of February 4, 2027, 2028 and 2029 and 40% vesting on February 4, 2030."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares (\"ADSs\"). Each ADS represents thirty-five ordinary shares of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares (\"ADSs\"). Each ADS represents thirty-five ordinary shares of the Issuer."}],"balance_after":8141,"derivative":{"exercise_price":7.37,"expiration_date":"2036-02-04","underlying":"ADS","underlying_shares":8141},"source":{"system":"sec-edgar","filing":"0001104659-26-011610","document":"tm265448-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107486/000110465926011610/tm265448-2_4seq1.xml","form_type":"4"}},{"id":1128111,"issuer":{"id":7876,"kind":"organization","name":"Quoin Pharmaceuticals Ltd."},"owners":[{"id":67443,"kind":"person","name":"SEMBER MICHAEL T","position":1,"cik":"0001107486","reported_name":"SEMBER MICHAEL T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2025-06-02T20:36:36.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":7760,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares (\"ADSs\"). Each ADS represents thirty-five ordinary shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F1","text":"The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares (\"ADSs\"). Each ADS represents thirty-five ordinary shares of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in four annual installments with 20% vesting on each of May 29, 2026, 2027 and 2028 and 40% vesting on May 29, 2029."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares (\"ADSs\"). Each ADS represents thirty-five ordinary shares of the Issuer."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares (\"ADSs\"). Each ADS represents thirty-five ordinary shares of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares (\"ADSs\"). Each ADS represents thirty-five ordinary shares of the Issuer."}],"balance_after":7760,"derivative":{"exercise_price":9.07,"expiration_date":"2035-05-29","underlying":"ADS","underlying_shares":7760},"source":{"system":"sec-edgar","filing":"0001104659-25-055626","document":"tm2516320-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107486/000110465925055626/tm2516320-1_4seq1.xml","form_type":"4"}},{"id":1337613,"issuer":{"id":7876,"kind":"organization","name":"Quoin Pharmaceuticals Ltd."},"owners":[{"id":67443,"kind":"person","name":"SEMBER MICHAEL T","position":1,"cik":"0001107486","reported_name":"SEMBER MICHAEL T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2024-12-10T16:47:57.000Z","date":"2024-12-09","kind":"grant","planned":false,"acquired":true,"shares":50714,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares (\"ADSs\"). Each ADS represents one ordinary share of the Issuer."},{"field":"shares","element":"transactionShares","label":"F1","text":"The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares (\"ADSs\"). Each ADS represents one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in four annual installments with 20% vesting on each of December 9, 2025, 2026 and 2027 and 40% vesting on December 9, 2028."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares (\"ADSs\"). Each ADS represents one ordinary share of the Issuer."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares (\"ADSs\"). Each ADS represents one ordinary share of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares (\"ADSs\"). Each ADS represents one ordinary share of the Issuer."}],"balance_after":50714,"derivative":{"exercise_price":0.78,"expiration_date":"2034-12-09","underlying":"ADS","underlying_shares":50714},"source":{"system":"sec-edgar","filing":"0001104659-24-127238","document":"tm2430519-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107486/000110465924127238/tm2430519-4_4seq1.xml","form_type":"4"}},{"id":1753942,"issuer":{"id":7876,"kind":"organization","name":"Quoin Pharmaceuticals Ltd."},"owners":[{"id":67443,"kind":"person","name":"SEMBER MICHAEL T","position":1,"cik":"0001107486","reported_name":"SEMBER MICHAEL T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2023-10-30T16:14:12.000Z","date":"2023-10-26","kind":"grant","planned":false,"acquired":true,"shares":7652,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares (\"ADSs\"), with sixty thousand (60,000) ordinary shares of the Issuer represented by one (1) ADS."},{"field":"shares","element":"transactionShares","label":"F1","text":"The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares (\"ADSs\"), with sixty thousand (60,000) ordinary shares of the Issuer represented by one (1) ADS."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in four annual installments with 20% vesting on each of October 26, 2024, 2025 and 2026 and 40% vesting on October 26, 2027."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares (\"ADSs\"), with sixty thousand (60,000) ordinary shares of the Issuer represented by one (1) ADS."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares (\"ADSs\"), with sixty thousand (60,000) ordinary shares of the Issuer represented by one (1) ADS."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares (\"ADSs\"), with sixty thousand (60,000) ordinary shares of the Issuer represented by one (1) ADS."}],"balance_after":7652,"derivative":{"exercise_price":5.75,"exercise_date":"2024-10-26","expiration_date":"2033-10-26","underlying":"American Depositary Share","underlying_shares":7652},"source":{"system":"sec-edgar","filing":"0001104659-23-112572","document":"tm2329341-8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107486/000110465923112572/tm2329341-8_4seq1.xml","form_type":"4"}}]}